Review of Mesna (Mistabron) as a Mucolytic for Preventing Plumonary complications in Intensive Care Setting.
Article
in English
| IMSEAR
| ID: sea-157619
ABSTRACT
Impaired mucus clearance or mucus hypersecretion are important feature of many pathological respiratory conditions and in ICU patients. Mesna is a potent mucolytic available as 200 mg/ml solution for neublization and endotracheopulmonary instillation. As effective “mucus clearance” is critical in managing post-operative and other ICU conditions to prevent complications like atelectasis and hypoxia, there is a need to review the clinical results of mucolytic agent Mesna, and its role in mucociliary clearance in critical care patients and in other respiratory conditions.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Antitussive Agents
/
Postoperative Complications
/
Respiration Disorders
/
Humans
/
Mucociliary Clearance
/
Mesna
/
Expectorants
/
Intensive Care Units
Language:
English
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS